Literature DB >> 6858129

Low-dose propranolol therapy for aborting migraine.

H J Featherstone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6858129      PMCID： PMC1021497     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  8 in total

1.  Ergotamine headache.

Authors:  P G Andersson
Journal:  Headache       Date:  1975-07       Impact factor: 5.887

2.  CLINICAL TRIAL OF INHALED ERGOTAMINE TARTRATE IN MIGRAINE.

Authors:  J CROOKS; S A STEPHEN; W BRASS
Journal:  Br Med J       Date:  1964-01-25

3.  A double-blind crossover trial of isometheptene mucate compound and ergotamine in migraine.

Authors:  G M Yuill; W R Swinburn; L A Liversedge
Journal:  Br J Clin Pract       Date:  1972-02

4.  The treatment of migraine with propranolol.

Authors:  R B Weber; O M Reinmuth
Journal:  Neurology       Date:  1972-04       Impact factor: 9.910

5.  Double blind study of propranolol for migraine prophylaxis.

Authors:  S Diamond; J L Medina
Journal:  Headache       Date:  1976-03       Impact factor: 5.887

6.  Toxic effects of ergotamine used for migraine.

Authors:  E Hokkanen; O Waltimo; T Kallanranta
Journal:  Headache       Date:  1978-05       Impact factor: 5.887

7.  Propranolol for acute migraine.

Authors:  R Tokola; E Hokkanen
Journal:  Br Med J       Date:  1978-10-14

8.  Controlled clinical trial of ergotamine tartrate.

Authors:  W E Waters
Journal:  Br Med J       Date:  1970-05-09
  8 in total
  2 in total

Review 1.  Vascular headache.

Authors:  K L Kumar; T G Cooney
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

2.  New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma.

Authors:  Ilknur Kozanoglu; Melis Kartal Yandim; Zeynep Birsu Cincin; Hakan Ozdogu; Bedia Cakmakoglu; Yusuf Baran
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-19       Impact factor: 4.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.